Impact of SGLT2 inhibitors on CV mortality, HF hospitalizations and clinical stability.
30 June 2021 (16:53 - 16:59)
Organised by:
About the speaker
Baylor University Medical Center, Dallas (United States of America)
5 More presentations in this session
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Professor G. Filippatos (Athens, GR)
Access the full session
The Event
Heart Failure 2021
30 June 2021
16:53 CET
You may be interested in
Congress Session
Congress Session
